Human papillomavirus (HPV)

Kenya has been systematically rolling out the HPV vaccine – which prevents the leading cause of cervical cancer – in schools.

Real world data from the UK shows the value of vaccinating girls against human papilloma virus (HPV) when they are 12 to 13 years of age.

COVID-19 has caused a decline in the delivery of human papillomavirus (HPV) vaccines that protect girls from cervical cancer. Anuradha Gupta, the Deputy CEO of Gavi, explains what we must do to create more access to these vaccines.

In Tanzania, the Ocean Road Cancer Institute is doing its part to ensure that people across the country can receive cancer treatment and care, regardless of their ability to pay.

Global access to HPV vaccine is vital, particularly in lower-income countries. Lessons learned from HPV roll-out could boost uptake of COVID-19 vaccines.

As World Cancer Day approaches amidst the COVID-19 pandemic,  it’s now more important than ever to ensure continued access to HPV vaccines to eliminate cervical cancer around the world.

The world’s most comprehensive study reveals all! A new study looking at the impact of vaccinations in 98 countries over the past 20 years concludes that 37 million people are alive today thanks to vaccines.

New review of evidence on a single-dose HPV vaccination schedule is published by PATH-led consortium.

New girl-centered toolkit helps health officials develop and implement communications campaigns that resonate with girls in their countries.

Nearly half a million girls to be protected each year following the launch of the HPV, which will be provided with financial support from Gavi, the Vaccine Alliance. Here’s a closer look at the launch ceremony.